Explore how precision medicine is transforming primary care through genomics, biomarkers, pharmacogenomics, risk prediction, and clinical decision support helping clinicians personalize prevention, treatment, and everyday patient care.
Discover how biomarkers are advancing precision immunology by improving the diagnosis, prognosis, and personalized treatment of autoimmune diseases such as rheumatoid arthritis, lupus, and inflammatory bowel disease.
Discover how genomics, biomarkers, and precision cardiology help identify cardiovascular risk early and enable personalized prevention.
Learn how genomic profiling identified an EGFR mutation and guided targeted therapy selection in a real-world precision oncology case.
Helping clinicians understand how genetic variation influences drug response
Advances in biomedical research have significantly expanded the role of molecular and physiological indicators in clinical decision-making. Among the most influential of these developments is the increasing use of biomarkers to guide diagnosis, risk assessment, treatment selection, and disease monitoring. Biomarker-guided medicine represents a core component of precision medicine, emphasizing the use of measurable biological signals to inform individualized clinical care.
A multidisciplinary community committed to advancing research, education, and clinical standards in precision medicine.
Copyright 2026. American Board of Precision Medicine. All Rights Reserved.
